Trials / Unknown
UnknownNCT05689801
Describe the Effect of the Optimized Hemodialysis Technique (HDx) With Medium Cut-Off Membrane on Recovery Time and Quality of Life
Pilot Study: Describe the Effect of the Optimized Hemodialysis Technique (HDx) With Medium Cut-Off Membrane on Recovery Time and Quality of Life
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Ramsay Générale de Santé · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the effect of optimizing the dialytic technique using simple questionnaires carried out in clinical routine will be described. More specifically, the conventional dialysis technique will be combined with biofeedback software called HemoControl™. The recovery time and quality of life of patients who will use a polyethersulfone membrane (Revaclear®) and a Medium Cut-Off (MCO) membrane (Theranova®) will be observed. The main objective is to describe the evolution of recovery time after a dialysis session in conventional hemodialysis (HD) on Revaclear® membrane and in so-called optimized hemodialysis (HDx) on MCO membrane, Theranova®.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaire "recovery time after a dialysis session". | A very short questionnaire just after the dialysis session |
| OTHER | SF-12 questionnaire | Questionnaire about quality of life of the patient |
| OTHER | EQ-5D-5L Questionnaire | Questionnaire about quality of life of the patient |
| OTHER | Pittman, John et McIntyre questionnaire | Questionnaire about quality of life of the patient under dialysis |
| PROCEDURE | Conventional hemodialysis | patient on polyethersulfone membrane dialysis (Revaclear®, Baxter) with HemoControl™ for 12 weeks |
| PROCEDURE | Optimized hemodialysis | patient on Medium Cut-Off membrane dialysis (Theranova®, Baxter) with HemoControl™ for 12 weeks. |
Timeline
- Start date
- 2022-12-15
- Primary completion
- 2023-06-15
- Completion
- 2024-01-15
- First posted
- 2023-01-19
- Last updated
- 2023-01-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05689801. Inclusion in this directory is not an endorsement.